# FDA 483 - Department of Defense - Air Force, 99th Medical Group - March 27, 2025

Source: https://www.globalkeysolutions.net/records/483/department-of-defense-air-force-99th-medical-group/7231d86d-3d18-4301-87c7-fb8b9f7412a5

> FDA 483 for Department of Defense - Air Force, 99th Medical Group on March 27, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Department of Defense - Air Force, 99th Medical Group
- Inspection Date: 2025-03-27
- Product Type: biologics
- Office Name: San Francisco District Office
- Summary: An FDA inspection of the Department of Defense - Air Force, 99th Medical Group blood bank in Nellis AFB, NV, revealed significant deficiencies. Observations included inadequate testing of a new computer system, failure to submit biological product deviation reports within the required timeframe, and incomplete documentation of investigations into unexplained discrepancies and product failures. These issues indicate a need for improved quality control and documentation practices.

## Related Officers

- [Emily B. Camire](https://www.globalkeysolutions.net/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)

Company: https://www.globalkeysolutions.net/companies/department-of-defense-air-force-99th-medical-group/95104b51-552b-409c-a66b-422dded58016

Office: https://www.globalkeysolutions.net/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df